● Recruiting

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Condition: Generalized Myasthenia Gravis · Sponsor: Vor Biopharma

PhasePhase 3

Planned participants180

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.

This description comes directly from the study's public registry record.

Talk to the study team

Jeremy Sokolove · 617-655-6580 · Study@vorbio.com

Always discuss trial participation with your own doctor first.

Locations (111)

HonorHealth Neurology - Bob Bové Neuroscience Institute	Scottsdale, Arizona, United States	Recruiting
University of Southern California	Los Angeles, California, United States	Recruiting
University of California Irvine	Orange, California, United States	Recruiting
University of California San Francisco (UCSF)	San Francisco, California, United States	Recruiting
SFM Clinical Research	Boca Raton, Florida, United States	Recruiting
Allied Biomedical Research Institute (ABRI)	Miami, Florida, United States	Recruiting
Medsol Clinical Research Center	Port Charlotte, Florida, United States	Recruiting
University of South Florida Health (USF Health)	Tampa, Florida, United States	Recruiting
Wellstar MCG Health Medical Center	Augusta, Georgia, United States	Recruiting
Hospital Sisters Health System Medical	O'Fallon, Illinois, United States	Recruiting
University of Kansas Medical Center	Kansas City, Kansas, United States	Recruiting
University of Kentucky	Lexington, Kentucky, United States	Recruiting

+ 99 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06456580